Inventor · disambiguated record
Muthusamy Jayaraman
Also filed as: JAYARAMAN MUTHUSAMY
66 granted patents·49 pending applications·2,501 citations·filing 1999–2025
99Inventor score
Files withALNYLAM PHARMACEUTICALS INC38ARBUTUS BIOPHARMA CORP28MANOHARAN MUTHIAH13RENAGADE THERAPEUTICS MAN INC13E THERAPEUTICS PLC11
Top patents by PatentIndex Score
115 records- 0199US9682139B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2015·Granted Jun 20, 2017·46 cites·20 claims
- 0298US11679158B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Jun 20, 2023·7 cites·13 claims
- 0398US11633479B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Apr 25, 2023·11 cites·24 claims
- 0498US11633480B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Apr 25, 2023·11 cites·28 claims
- 0598US11612657B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Mar 28, 2023·9 cites·30 claims
- 0698US11590229B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Feb 28, 2023·11 cites·29 claims
- 0798US11382979B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Jul 12, 2022·18 cites·30 claims
- 0898US11246933B1Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Feb 15, 2022·30 cites·28 claims
- 0998US10369226B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Aug 6, 2019·25 cites·42 claims
- 1098US9345780B2Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic componentsTEKMIRA PHARMACEUTICALS CORP·Filed 2013·Granted May 24, 2016·255 cites·10 claims
- 1198US9186325B2Lipids and compositions for the delivery of therapeuticsMANOHARAN MUTHIAH·Filed 2009·Granted Nov 17, 2015·100 cites·19 claims
- 1298US9061063B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Jun 23, 2015·41 cites·32 claims
- 1398US9012498B2Biodegradable lipids for the delivery of active agentsMANOHARAN MUTHIAH·Filed 2011·Granted Apr 21, 2015·104 cites·41 claims
- 1498US8999351B2Lipids and compositions for the delivery of therapeuticsMANOHARAN MUTHIAH·Filed 2009·Granted Apr 7, 2015·102 cites·15 claims
- 1598US8883202B2Lipid compositionsMANOHARAN MUTHIAH·Filed 2010·Granted Nov 11, 2014·104 cites·22 claims
- 1698US8642076B2Lipid containing formulationsMANOHARAN MUTHIAH·Filed 2011·Granted Feb 4, 2014·155 cites·28 claims
- 1798US8575123B2Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic componentsMANOHARAN MUTHIAH·Filed 2009·Granted Nov 5, 2013·82 cites·39 claims
- 1897US9764036B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2015·Granted Sep 19, 2017·19 cites·22 claims
- 1997US9682922B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Jun 20, 2017·39 cites·18 claims
- 2097US9394234B2Lipid formulationsTEKMIRA PHARMACEUTICALS CORP·Filed 2014·Granted Jul 19, 2016·117 cites·10 claims
- 2197US8802644B2Lipid formulationCHEN JIANXIN·Filed 2012·Granted Aug 12, 2014·124 cites·35 claims
- 2297US8722082B2Lipids and compositions for the delivery of therapeuticsMANOHARAN MUTHIAH·Filed 2009·Granted May 13, 2014·44 cites·25 claims
- 2397US8507455B2Folate conjugatesMANOHARAN MUTHIAH·Filed 2008·Granted Aug 13, 2013·32 cites·14 claims
- 2497US8158601B2Lipid formulationCHEN JIANXIN·Filed 2010·Granted Apr 17, 2012·777 cites·30 claims
- 2596US11504391B1Modified RNA agents with reduced off-target effectALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Nov 22, 2022·18 cites·42 claims
- 2696US11071784B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Jul 27, 2021·5 cites·1 claims
- 2796US10117941B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2017·Granted Nov 6, 2018·12 cites·14 claims
- 2896US9687550B2Compositions for nucleic acid deliveryMANOHARAN MUTHIAH·Filed 2010·Granted Jun 27, 2017·21 cites·5 claims
- 2995US11400158B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Aug 2, 2022·1 cites·30 claims
- 3095US10821186B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2018·Granted Nov 3, 2020·4 cites·24 claims
- 3195US9220683B2Lipids and compositions for the delivery of therapeuticsMANOHARAN MUTHIAH·Filed 2009·Granted Dec 29, 2015·28 cites·17 claims
- 3294US10995336B2Serpina1 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted May 4, 2021·8 cites·41 claims
- 3393US12453776B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2024·Granted Oct 28, 2025·0 cites·46 claims
- 3493US11077197B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2017·Granted Aug 3, 2021·3 cites·17 claims
- 3592US12364762B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Jul 22, 2025·0 cites·14 claims
- 3692US12350338B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Jul 8, 2025·0 cites·14 claims
- 3792US12343398B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Jul 1, 2025·0 cites·30 claims
- 3892US12239709B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Mar 4, 2025·0 cites·28 claims
- 3992US8962580B2Chemical modifications of monomers and oligonucleotides with cycloadditionMANOHARAN MUTHIAH·Filed 2009·Granted Feb 24, 2015·26 cites·11 claims
- 4091US11420931B2Lipid containing formulationsARBUTUS BIOPHARMA CORP·Filed 2019·Granted Aug 23, 2022·2 cites·20 claims
- 4191US9814777B2Targeting lipidsARBUTUS BIOPHARMA CORP·Filed 2013·Granted Nov 14, 2017·8 cites·11 claims
- 4291US9707292B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2015·Granted Jul 18, 2017·5 cites·12 claims
- 4391US2024398956A1Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4490US10456473B2Lipid compositionsARBUTUS BIOPHARMA CORP·Filed 2017·Granted Oct 29, 2019·6 cites·8 claims
- 4590US9999673B2PEGylated lipids and their use for drug deliveryRAJEEV KALLANTHOTTATHIL G·Filed 2012·Granted Jun 19, 2018·18 cites·29 claims
- 4689US12042541B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2023·Granted Jul 23, 2024·0 cites·23 claims
- 4788US11725207B2Serpina1 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Aug 15, 2023·1 cites·123 claims
- 4888US6509344B1Indenoisoquinolines as antineoplastic agentsUS HEALTH·Filed 1999·Granted Jan 21, 2003·52 cites·54 claims
- 4988US2023381319A1Novel lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 5088US2023256098A1Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 115 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Muthusamy Jayaraman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →